Pacific Biosciences Of California (PACB) Long-Term Debt Repayments (2017 - 2024)
Pacific Biosciences Of California's quarterly Long-Term Debt Repayments came in at $152000.0 in Q2 2024, down 67.31% year-on-year from $465000.0 in Q3 2023, and down 55.03% quarter-over-quarter from $338000.0 in Q1 2024.
Pacific Biosciences Of California has reported Long-Term Debt Repayments for 5 years, with the latest figure at $152000.0 in Q2 2024.
- For the quarter ending Q2 2024, Long-Term Debt Repayments fell 67.31% year-over-year to $152000.0; the trailing twelve-month figure through Mar 2025 stood at $152000.0 (down 91.23% YoY), and the FY2024 full-year result was $490000.0, down 73.4% from the prior year.
- Long-Term Debt Repayments for Q2 2024 stood at $152000.0, down from $338000.0 in the prior quarter.
- The five-year high for Long-Term Debt Repayments was $16.0 million in Q1 2020, with the low at $152000.0 in Q2 2024.
- Average Long-Term Debt Repayments over 4 years is $1.8 million, with a median of $428000.0 recorded in 2022.
- Year-over-year, Long-Term Debt Repayments climbed 18.54% in 2023 and sank 67.31% in 2024.
- Tracing PACB's Long-Term Debt Repayments over 4 years: stood at $16.0 million in 2020, then plunged by 97.32% to $428000.0 in 2022, then grew by 3.97% to $445000.0 in 2023, then plunged by 65.84% to $152000.0 in 2024.
- The last three Long-Term Debt Repayments figures came in at $152000.0 (Q2 2024), $338000.0 (Q1 2024), and $445000.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 152,000.00 |
| Jun 30, 2024 | 152,000.00 |
| Mar 31, 2024 | 338,000.00 |
| Mar 31, 2024 | 338,000.00 |
| Dec 31, 2023 | 445,000.00 |
| Dec 31, 2023 | 445,000.00 |
| Sep 30, 2023 | 486,000.00 |
| Sep 30, 2023 | 486,000.00 |
| Jun 30, 2023 | 465,000.00 |
| Jun 30, 2023 | 465,000.00 |
| Mar 31, 2023 | 446,000.00 |
| Mar 31, 2023 | 446,000.00 |
| Dec 31, 2022 | 428,000.00 |
| Dec 31, 2022 | 428,000.00 |
| Sep 30, 2022 | 410,000.00 |
| Sep 30, 2022 | 410,000.00 |
| Jun 30, 2022 | 393,000.00 |
| Jun 30, 2022 | 393,000.00 |
| Mar 31, 2022 | 377,000.00 |
| Mar 31, 2022 | 377,000.00 |
| Mar 31, 2020 | 16.00 Mn |
| Mar 31, 2020 | 16.00 Mn |
| Jun 30, 2017 | 4.50 Mn |
| Jun 30, 2017 | 4.50 Mn |